Managing obesity in women

Ben Falkenmire

writer

Ben Falkenmire

Writer

Ben Falkenmire

 

For 31% of the Australian adult population living with obesity, exercise and diet will only help 1 in 20 to reduce weight. How can GPs treat the vast majority of obese patients?

Very low calorie diets (VLCDs) are a highly effective tool that can be used throughout a patient’s lifetime, says Professor John Dixon, head of clinical obesity research at the Baker Heart and Diabetes Institute.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking

A/Prof Samantha Hocking

Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence

A/Prof Gino Pecoraro OAM

A/Prof Gino Pecoraro OAM

Genitourinary Syndrome of Menopause – Mythbusting for GPs

Prof Sonia Grover

Prof Sonia Grover

Dysmenorrhoea in Teens

Prof Paul Griffin

Prof Paul Griffin

Winter Virus Preparations

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Ben Falkenmire

writer

Ben Falkenmire

Writer

Test your knowledge

Recent articles

Latest GP poll

"I am concerned about disrupted continuity of care for patients that use 1800Medicare"

Strongly agree

0%

Slightly agree

0%

Slightly disagree

0%

Strongly disagree

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease